Epidemiology, definition and treatment of complicated urinary tract infections

FME Wagenlehner, TE Bjerklund Johansen… - Nature Reviews …, 2020 - nature.com
UTIs are amongst the most frequent bacterial infections. However, the clinical phenotypes of
UTI are heterogeneous and range from rather benign, uncomplicated infections to …

Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline

SE Boyd, DM Livermore, DC Hooper… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Modern medicine is threatened by the global rise of antibiotic resistance, especially among
Gram-negative bacteria. Metallo-β-lactamase (MBL) enzymes are a particular concern and …

Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents

MS Bader, M Loeb, D Leto, AA Brooks - Postgraduate medicine, 2020 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited treatment options. Knowledge of the common uropathogens …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - academic.oup.com
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

[HTML][HTML] Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an …

S Karakonstantis, EI Kritsotakis, A Gikas - Infection, 2020 - Springer
The management of carbapenem-resistant infections is often based on polymyxins,
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …

[HTML][HTML] Carbapenem-sparing strategies for ESBL producers: when and how

I Karaiskos, H Giamarellou - Antibiotics, 2020 - mdpi.com
Extended spectrum β-lactamase (ESBL)-producing bacteria are prevalent worldwide and
correlated with hospital infections, but they have been evolving as an increasing cause of …

[HTML][HTML] Fosfomycin as partner drug for systemic infection management. A systematic review of its synergistic properties from in vitro and in vivo studies

RM Antonello, L Principe, AE Maraolo, V Viaggi, R Pol… - Antibiotics, 2020 - mdpi.com
Fosfomycin is being increasingly prescribed for multidrug-resistant bacterial infections. In
patients with systemic involvement, intravenous fosfomycin is usually administered as a …

[HTML][HTML] Carbapenem-resistant Enterobacterales: considerations for treatment in the era of new antimicrobials and evolving enzymology

MJ Lasko, DP Nicolau - Current infectious disease reports, 2020 - Springer
Abstract Purpose of Review Gram-negative resistance is a growing concern globally.
Enterobacterales, formerly Enterobacteriaceae, have developed resistance mechanisms to …

Fosfomycin for bacterial prostatitis: a review

ACF Kwan, NP Beahm - International journal of antimicrobial agents, 2020 - Elsevier
There has been growing interest in fosfomycin for the treatment of bacterial prostatitis due to
evidence suggesting that it achieves adequate prostatic concentrations for antimicrobial …

[HTML][HTML] Management of infections caused by WHO critical priority Gram-negative pathogens in Arab countries of the Middle East: a consensus paper

J Al Salman, L Al Dabal, M Bassetti… - International journal of …, 2020 - Elsevier
Antimicrobial resistance is an important global issue that impacts the efficacy of established
antimicrobial therapy. This is true globally and within the Arab countries of the Middle East …